Abstract:After an introduction showing the growing interest in glasses and glass-ceramics as biomaterials used for bone healing, we describe a new biomaterial named Biosilicate. Biosilicate is the designation of a group of fully crystallized glass-ceramics of the Na2O-CaO-SiO2-P2O5 system. Several in vitro tests have shown that Biosilicate is a very active biomaterial and that the HCA layer is formed in less than 24 hours of exposure to “simulated body fluid” (SBF) solution. Also, in vitro studies with osteoblastic cel… Show more
“…[14][15][16][17][18] In particular, the use of a new glass-ceramic powder called Biosilicate has been proposed as a therapeutic agent for enamel and dentin regeneration because of the faster deposition of a hydroxyapatite layer where the product is applied. 6,18,19 Biosilicate particles appear to react rapidly with surrounding tissue inside the dentin microchannels 18 resulting in an effective clinical reduction in sensitivity by promoting the occlusion of dentin tubules. 20 When used immediately after bleaching treatment, Biosilicate can reduce or even prevent the demineralization effect of bleaching products and prevent the exposure of dentin tubules.…”
“…[14][15][16][17][18] In particular, the use of a new glass-ceramic powder called Biosilicate has been proposed as a therapeutic agent for enamel and dentin regeneration because of the faster deposition of a hydroxyapatite layer where the product is applied. 6,18,19 Biosilicate particles appear to react rapidly with surrounding tissue inside the dentin microchannels 18 resulting in an effective clinical reduction in sensitivity by promoting the occlusion of dentin tubules. 20 When used immediately after bleaching treatment, Biosilicate can reduce or even prevent the demineralization effect of bleaching products and prevent the exposure of dentin tubules.…”
“…Renno and Vivan suggested that for satisfactory biological interaction to occur, bone replacement graft materials must not only be biocompatible but must also present a high bioactive level resulting in over 50% of living tissue (new bone) being attached to a material surface. This attachment is established through the formation of a layer of biologically active hydroxycarbonate apatite at the material/tissue interface, quite similar to bone tissue apatite.…”
“…It should be kept in mind that, while, this holds true for crystallization of typical bioactive glasses, glass-ceramic with tailored crystal composition, size and density can be produced with bioactivity similar to Bioglass ®. Biosilicate is one such material showing promising results both in-vitro and in-vivo [13]. As of today, 3D scaffold obtained via thermal bonding [14][15] and polymer foam replication [16][17][18] can be mainly classified as glass-ceramic.…”
Typical silicate bioactive glasses are known to crystallize readily during the processing of porous scaffolds. While such crystallization does not fully suppress the bioactivity, the presence of significantly large amounts of crystals leads to a decrease in the rate of reaction of the glass and an uncontrolled release of ions. Furthermore, due to the non-congruent dissolution of silicate glasses, these materials have been shown to remain within the surgical site even 14 years postoperation. Therefore, a need for bioactive materials that can dissolve with higher conversion rates and more effectively are required. Within this work, boron was introduced, in the FDA approved S53P4 glass, at the expense of SiO2. The crystallization and sintering-ability of the newly developed glasses were investigated by differential thermal analysis. All the glasses were found to crystallize primarily from the surface, and the crystal phase precipitating was dependent upon the quantity of B2O3 incorporated. The rate of crystallization was found to be lower for the glasses were 25, 50 and 75 % of the SiO2 was replaced with B2O3. These glasses were further sintered into porous scaffolds using simple heat sintering. The impact of glass particles size and heat treatment temperature on the scaffolds porosity and average pore size was investigated. Scaffolds with porosity ranging from 10 to 60 % with compressive strength ranging from 1 to 35 MPa, were produced. The scaffolds remained amorphous during processing and their ability to rapidly precipitate hydroxycarbonated apatite was maintained. This is of particular interest in the field of tissue engineering as the scaffolds degradation and reaction was generally faster and offers higher controllability as opposed to current partially/fully crystallized scaffolds obtained from the FDA approved bioactive glasses.
IntroductionAs of today, autografts are still the gold standard for the repair of large bone defects. However, with the aging and growing population, the number of surgical intervention to regenerate bone defects are increasing. The limited supply and patient site morbidity is a well-known disadvantage and problem [1][2]. Allografts are an option. However, the limited tissue bank as well as the higher risk for infection and cellular and humoral immune reactions limits their usage [3]. The quest for synthetic biomaterials to replace the autografts is more than two decades old. However, as of today no materials have shown as promising a result as autografts. Q. Chen et al. have reported the optimum characteristic that the synthetic materials should have to find great potential as bone grafts [4]. The bone graft should be a 3D construct (3D scaffold) not only biocompatible, but ultimately biodegradable and osteoconductive with highly interconnected porosity. Pore size should be no less than 100 µm to allow cell and fluid penetration as well as angiogenesis. In general, interconnected pores of at least 100 µm and an open porosity of over 50% is considered the minimum requirement for ti...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.